Samuel Lam, PhD, Vice President of Science and Research at Immunophotonics, Inc. and Markus Joerger, MD, PhD, Clinical Trial Principal Investigator spoke at the US Oncology Research BioTech Day, Early Development Program (EDP) Summit in Coronado, California, on April 27, 2022 at 1:00 p.m. in the Glorietta Room.
Immunophotonics thanks Dr. Dan Von Hoff and Dr. Robert Colman for inviting Dr. Lam to speak at this event. Dr. Lam discussed Immunophotonics’ technology, the results of our early clinical trials, and about our upcoming clinical programs. Dr. Joerger discussed our clinical case study.
The purpose of the US Oncology Early Development Program (EDP) is to hear about new science connected to an upcoming or ongoing phase I/II trial. The Immunophotonics team was excited to be able to participate and receive feedback from their investigators.